Sensei Biotherapeutics (SNSE) Insider Trading & Ownership $0.46 -0.01 (-2.07%) As of 12:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Sensei Biotherapeutics (NASDAQ:SNSE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.00%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$3,967.00Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$5.44 M Get SNSE Insider Trade Alerts Want to know when executives and insiders are buying or selling Sensei Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SNSE Insider Buying and Selling by Quarter Remove Ads Sensei Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/11/2023John CelebiCEOBuy500$0.85$425.00 6/1/2023Apeiron Investment Group Ltd.Major ShareholderSell3,441,661$1.58$5,437,824.38 2/23/2023Apeiron Investment Group Ltd.Major ShareholderBuy2,200$1.61$3,542.00 (Data available from 1/1/2013 forward) SNSE Insider Trading Activity - Frequently Asked Questions Who is on Sensei Biotherapeutics's Insider Roster? The list of insiders at Sensei Biotherapeutics includes Apeiron Investment Group Ltd., and John Celebi. Learn more on insiders at SNSE. What percentage of Sensei Biotherapeutics stock is owned by insiders? 22.00% of Sensei Biotherapeutics stock is owned by insiders. Learn more on SNSE's insider holdings. Which Sensei Biotherapeutics insiders have been buying company stock? The following insider purchased SNSE shares in the last 24 months: John Celebi ($425.00). How much insider buying is happening at Sensei Biotherapeutics? Insiders have purchased a total of 500 SNSE shares in the last 24 months for a total of $425.00 bought. Which Sensei Biotherapeutics insiders have been selling company stock? The following insider sold SNSE shares in the last 24 months: Apeiron Investment Group Ltd. ($5,437,824.38). How much insider selling is happening at Sensei Biotherapeutics? Insiders have sold a total of 3,441,661 Sensei Biotherapeutics shares in the last 24 months for a total of $5,437,824.38 sold. Sensei Biotherapeutics Key ExecutivesMr. John K. Celebi M.B.A. (Age 52)President, CEO & Director Compensation: $882.28kDr. Edward Van der Horst Ph.D. (Age 50)Chief Scientific Officer Compensation: $630.81kMs. Lora PikeVice President of Investor Relations & CommunicationsMr. Christopher W. Gerry J.D.Senior VP, General Counsel & SecretaryMs. Stephanie Krebs M.B.A. (Age 46)M.S., Chief Business Officer Dr. Aaron Weitzman FACPM.D., Ph.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies ICCC Insider Selling SCYX Insider Selling KZR Insider Selling KALA Insider Selling ATRA Insider Selling LTRN Insider Selling SPRO Insider Selling ALXO Insider Selling XLO Insider Selling PRLD Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling This page (NASDAQ:SNSE) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensei Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensei Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNSE Stock Free SNSE Stock Alerts